NUVL FY 2022 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$86M

Net Income

-$82M

EPS (Diluted)

$-1.65

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$65M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$482M

Total Liabilities

$19M

Stockholders' Equity

$463M

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$86M	-$46M	-87.9%
Net Income	-$82M	-$46M	-76.6%